Obesity
Conference Coverage
Half of teens drop below obesity cutoff with semaglutide
The semaglutide findings are “historically unprecedented with treatments other than bariatric surgery.”
Conference Coverage
Obesity drug with swallowable balloon boosts weight loss
“In Europe, use of the swallowable gastric balloon is common, the results are good, and it is a safe tool.”
From the Journals
How BMI over time impacts GI cancer risk
These “important findings highlight the unmet need to identify the critical time window linking adiposity and GI cancer.”
Conference Coverage
Endoscopic sleeve gastroplasty plus obesity drugs add up to more weight loss
Some experts believe weight-loss medications can help with the rebound in weight that some people experience months after bariatric surgery.
Conference Coverage
Bariatric surgery cuts risk for obesity-related cancers in half: Study
For years evidence has pointed to multiple health benefits associated with bariatric surgery, including improvements in diabetes, sleep apnea, and...
Feature
Optimal time period for weight loss drugs: Debate continues
“Without the medicine, there are a variety of things that will happen. Appetite will tend to increase, and so [patients] will gradually tend to...
Latest News
Should GI own the obesity field?
Gastroenterologists speaking at the AGA Tech Summit discuss the use of devices used to treat obesity.
From the Journals
Longer life after bariatric surgery, but suicide risk in young
Death from diabetes was 72% lower in the bariatric surgery patients versus nonsurgery peers.
From the AGA Journals
Could boosting fat taste receptors help cut calories?
In mice, fat taste receptor agonists added to food promoted satiation and weight loss.
From the Journals
Diet packed with fast food found hard on the liver
“Striking” elevations in steatosis were evident among persons with obesity and diabetes who consumed fast food, in comparison with their...